O8.04 TEMOZOLOMIDE AFTER RADIOTHERAPY IN RECURRENT “LOW-GRADE” DIFFUSE BRAINSTEM GLIOMA IN ADULTS

por Reyes-Botero, G., Laigle-Donadey, F., Mokhtari, K., Martin-Duverneuil, N., Delattre, J.Y.
Publicado em 2014

P04.14 IDH1 MUTATION IN LOW-GRADE GLIOMAS RELATED TO EPILEPSY AS INITIAL SYMPTOM

por Duran-Peña, A., Mokhtari, K., Marie, Y., Alentorn, A., Delattre, J., Idbaih, A., Sanson, M., Vecht, C.
Publicado em 2014

Interleukin-6 gene amplification and shortened survival in glioblastoma patients

por Tchirkov, A, Khalil, T, Chautard, E, Mokhtari, K, Véronèse, L, Irthum, B, Vago, P, Kémény, J-L, Verrelle, P
Publicado em 2007

P11.04 MALT CNS LYMPHOMAS: A MONOCENTRIC EXPERIENCE

por Larrieu, D., Choquet, S., Hoang-Xuan, K., Mokhtari, K., Navarro, S., Martin-Duverneuil, N., Leblond, V., Charlotte, F., Houillier, C.
Publicado em 2014

O8.08 CIC MUTATION IS A POOR PROGNOSIS FACTOR IN 1P19Q CODELETED GLIOMAS, ASSOCIATED TO AN UP-REGULATION OF PROLIFERATION PATHWAYS

por Gleize, V., Alentorn, A., Connen de Kérillis, L., Labussière, M., Mangesius, S., Ducray, F., Mokhtari, K., Villa, C., Sanson, M.
Publicado em 2014

P04.10 IDH-wildtype low grade gliomas: overall survival and prognostic indicators

por Berzero, G, Di Stefano, A, Ronchi, S, Villa, C, Marie, Y, Hoang-Xuan, K, Delattre, J, Mokhtari, K, Sanson, M
Publicado no Neuro Oncol (2019)

O6.08 COMBINED ANALYSIS OF TERT, EGFR AND IDH STATUS DEFINE DISTINCT PROGNOSTIC CLASSES OF GLIOBLASTOMA

por Labussiere, M., Boisselier, B., Mokhtari, K., Di Stefano, A., Rahimian, A., Saulnier, O., Paterra, R., Finocchiaro, G., Marie, Y., Sanson, M.
Publicado em 2014

P01.148 Intra-tumor heterogeneity analysis of low-grade gliomas. A POLA Network study

por Alentorn, A, Labreche, K, Dehais, C, Carpentier, C, Ducray, F, Mokhtari, K, Figarella-Branger, D, Sanson, M, Delattre, J, Idbaih, A
Publicado no Neuro Oncol (2018)

O6.07 FGFR3-TACC3 AND EGFR-SEPT14 GENE FUSIONS IN ADULT GLIOMAS

por Di Stefano, A. L., Labussiere, M., Frattini, V., Fucci, A., Boisselier, B., Schmitt, Y., Mokhtari, K., Lasorella, A., Iavarone, A., Sanson, M.
Publicado em 2014

P06.18 DNA methylation distance score in lower-grade gliomas has prognostic value: a POLA network study

por Alentorn, A., Kamoun, A., Ducray, F., Dehais, C., Mokhtari, K., Uro-Coste, E., Figarella-Branger, D., Delattre, J., Idbaih, A., Sanson, M.
Publicado no Neuro Oncol (2016)

P06.19 TERT promoter mutation is an independent prognostic factor in 1p/19q co-deleted oligodendrogliomas: a POLA network study

por Alentorn, A., Carpentier, C., Labreche, K., Ducray, F., Dehais, C., Mokhtari, K., Uro-Coste, E., Figarella-Branger, D., Delattre, J., Idbaih, A.
Publicado no Neuro Oncol (2016)

P07.15 Diagnostic value of 2-hydroxyglutarate detection by 1H MR spectroscopy in patients with glioma and correlations with tumor phenotype and tissue dosage

por Di Stefano, A. L., Branzoli, F., Ottolenghi, C., Capelle, L., Mokhtari, K., Villa, C. M., Giry, M., Marjanska, M., Lehericy, S., Sanson, M.
Publicado no Neuro Oncol (2016)

O10.02 MITOTIC INDEX, MICROVASCULAR PROLIFERATION AND NECROSIS DEFINE THREE GROUPS OF 1P/19Q CO-DELETED ANAPLASTIC OLIGODENDROGLIOMAS ASSOCIATED WITH DIFFERENT GENOMIC ALTERATIONS

por Figarella-Branger, D., Mokhtari, K., Dehais, C., Jouvet, A., Uro-Coste, E., Colin, C., Carpentier, C., Ducray, F., Idbaih, A., Network, French POLA
Publicado em 2014

P17.04 Radiomics analysis of primary central nervous system lymphoma (PCNSL) - A LOC network study

por Royer-Perron, L., Bruno, A., Daniau, M., Labrèche, K., Mokhtari, K., Nguyen Them, L., Houillier, C., Soussain, C., Hoang-Xuan, K., Alentorn, A.
Publicado no Neuro Oncol (2016)

P17.01 CHROMOSOME ARM 9P LOSS OF HETEROZYGOSITY IS A MARKER OF SHORTER SURVIVAL IN 1P/19Q CO-DELETED ANAPLASTIC OLIGODENDROGLIOMA. A POLA NETWORK STUDY

por Alentorn, A., Dehais, C., Carpentier, C., Mokhtari, K., Ducray, F., Figarella-Branger, D., Delattre, J., Idbaih, A., (POLA)”, POLA Network “Prise en charge des OLigodendrogliomes Anaplasiques
Publicado em 2014

OS9.7 Telomere length, TERTp mutation and ALT status in adult diffuse gliomas

por Birzu, C, Hillairet, A, Giry, M, Grandin, N, Verrelle, P, Mokhtari, K, Marie, Y, Hoang-Xuan, K, Delattre, J, Idbaih, A, Charbonneau, M, Sanson, M, Alentorn, A
Publicado no Neuro Oncol (2019)

PL1.1 CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDHmutant gliomas

por Appay, R, Dehais, C, Colin, C, Alentorn, A, Carpentier, C, Ducray, F, Ibdaih, A, Kamoun, A, Mokhtari, K, Tabouret, E, Uro-Coste, E, Delattre, J, Figarella-Branger, D
Publicado no Neuro Oncol (2019)

OS9.2 Radiomics analysis of lower-grade gliomas, a POLA Network study

por Younan, N, Douzane, H, Duran-Pena, A, Nichelli, L, Garcilazo, Y, Dehais, C, Ducray, F, Carpentier, C, Mokhtari, K, Figarella-Branger, D, Delattre, J, Idbaih, A, Alentorn, A
Publicado no Neuro Oncol (2019)

P14.87 Leptomeningeal dissemination in high grade glioma: Correlation of MRI, cytology and standard CSF indices

por Durand, H, Lamy, F, Parratte, T, Brinet, A, Blain, A, Lamy, F, Gaultier, C, Droy-Dupré, L, Leblanc, S, Oesterlé, H, Olteanu, S, Atlani, D, Voirin, J, Mokhtari, K, Ahle, G
Publicado no Neuro Oncol (2019)

OS9.3 Clinical, molecular and radiomic profile of gliomas with FGFR3-TACC3 fusion

por Picca, A, Alentorn, A, Saragoussi, E, Bielle, F, Ducray, F, Villa, C, Schmitt, Y, Lerond, J, Leclerc, J, Lasorella, A, Iavarone, A, Mokhtari, K, Savatovsky, J, Sanson, M, Di Stefano, A
Publicado no Neuro Oncol (2019)